Chowdhury Moumita Ghosh, Kalmegh Vaishnavi, Kapoor Saumya, Kamble Vaishnavi, Shard Amit
Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research Ahmedabad (NIPER-A) Opposite Airforce Station, Palaj Gandhinagar Gujarat-382355 India
RSC Med Chem. 2024 Mar 13;15(5):1488-1507. doi: 10.1039/d3md00718a. eCollection 2024 May 22.
Nitrogen-fused heterocycles are of immense importance in modern drug discovery and development. Among them, imidazopyrimidine is a highly versatile scaffold with vast pharmacological utility. These compounds demonstrate a broad spectrum of pharmacological actions, including antiviral, antifungal, anti-inflammatory, and anticancer. Their adaptable structure allows for extensive structural modifications, which can be utilized for optimizing pharmacological effects structure-activity relationship (SAR) studies. Additionally, imidazopyrimidine derivatives are particularly noteworthy for their ability to target specific molecular entities, such as protein kinases, which are crucial components of various cellular signaling pathways associated with multiple diseases. Despite the evident importance of imidazopyrimidines in drug discovery, there is a notable lack of a comprehensive review that outlines their role in this field. This review highlights the ongoing interest and investment in exploring the therapeutic potential of imidazopyrimidine compounds, underscoring their pivotal role in shaping the future of drug discovery and clinical medicine.
氮杂环在现代药物研发中具有极其重要的意义。其中,咪唑并嘧啶是一种具有广泛药理用途的高度通用的骨架。这些化合物表现出广泛的药理作用,包括抗病毒、抗真菌、抗炎和抗癌。它们适应性强的结构允许进行广泛的结构修饰,可用于优化药理作用和构效关系(SAR)研究。此外,咪唑并嘧啶衍生物因其能够靶向特定分子实体(如蛋白激酶)而特别值得关注,蛋白激酶是与多种疾病相关的各种细胞信号通路的关键组成部分。尽管咪唑并嘧啶在药物研发中具有明显的重要性,但明显缺乏一篇全面概述其在该领域作用的综述。本综述强调了在探索咪唑并嘧啶化合物治疗潜力方面持续的兴趣和投入,突显了它们在塑造药物研发和临床医学未来方面的关键作用。